Erratum to: Multicentre randomized controlled trial comparing ferric(III) carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients
نویسندگان
چکیده
Author details Department of Surgery, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Department of Gastroenterology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Clinical Research Unit, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Department of Surgery, VU University Medical Centre, Amsterdam, The Netherlands. Department of Surgery, Meander Medical Centre, Amersfoort, The Netherlands. Department of Surgery, Borstlap et al. BMC Surgery (2015) 15:78 Spaarne Hospital, Hoofddorp, The Netherlands. Department of Surgery, Tergooi Hospital, Hilversum, The Netherlands. Department of Surgery, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands. Department of Gastroenterology, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands. Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Department of Gastroenterology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. Department of Surgery, Flevo Hospital, Almere, The Netherlands. Department of Surgery, Gelre Hospital, Apeldoorn, The Netherlands. Department of Surgery, Isala Hospital, Zwolle, The Netherlands. Department of Surgery, St. Vincent’s Hospital, Dublin, Ireland.
منابع مشابه
Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients
BACKGROUND At least a third of patients with a colorectal carcinoma who are candidate for surgery, are anaemic preoperatively. Preoperative anaemia is associated with increased morbidity and mortality. In general practice, little attention is paid to these anaemic patients. Some will have oral iron prescribed others not. The waiting period prior to elective colorectal surgery could be used to o...
متن کاملCost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia.
BACKGROUND Ferric Carboxymaltose (FCM), Iron Sucrose (IS) and Oral Iron (OI) are alternative treatments for preoperative anaemia. OBJECTIVE To compare the cost implications, using a cost-minimization analysis, of three alternatives: FCM vs. IS vs. OI for treating iron-deficient anaemia before surgery in patients with colon cancer. METHODS Data from 282 patients with colorectal cancer and an...
متن کاملRandomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty.
BACKGROUND Despite preoperative anaemia treatment, a risk of postoperative anaemia remains. This randomized, controlled study evaluated the efficacy of i.v. ferric carboxymaltose (FCM) as postoperative anaemia treatment after total knee arthroplasty (TKA). METHODS TKA patients with postoperative anaemia [haemoglobin (Hb) 8.5-12.0 g dl(-1)] without prior transfusions were randomly assigned to ...
متن کاملIntravenous ferric carboxymaltose for anaemia in pregnancy
BACKGROUND Iron deficiency is a common nutritional deficiency amongst women of childbearing age. Peri-partum iron deficiency anaemia (IDA) is associated with significant maternal, fetal and infant morbidity. Current options for treatment are limited: these include oral iron supplementation, which can be ineffective and poorly tolerated, and red blood cell transfusions, which carry an inherent r...
متن کاملThe FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
BACKGROUND Rigorous data are sparse concerning the optimal route of administration and dosing strategy for iron therapy with or without concomitant erythropoiesis-stimulating agent (ESA) therapy for the management of iron deficiency anaemia in patients with non-dialysis dependent chronic kidney disease (ND-CKD). METHODS FIND-CKD was a 56-week, open-label, multicentre, prospective, randomized ...
متن کامل